See the DrugPatentWatch profile for tigecycline

Pre-Tigecycline Liver Tests: A Comprehensive Guide

Tigecycline, a broad-spectrum antibiotic, has revolutionized the treatment of various bacterial infections. However, its use is not without risks, particularly concerning liver function. As a result, it is essential to conduct thorough liver tests before initiating tigecycline therapy. In this article, we will delve into the recommended liver tests that should precede tigecycline use.

Understanding Tigecycline's Liver Toxicity

Tigecycline, a derivative of minocycline, has been associated with liver toxicity, including elevated liver enzymes and, in rare cases, liver failure. The exact mechanism of tigecycline-induced liver injury is not fully understood, but it is believed to involve mitochondrial damage and oxidative stress.

Recommended Liver Tests Before Tigecycline Use

To minimize the risk of liver toxicity, it is crucial to conduct the following liver tests before initiating tigecycline therapy:

1. Liver Function Tests (LFTs)

LFTs, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and bilirubin, should be performed before starting tigecycline. These tests will help identify any pre-existing liver damage or dysfunction.

2. Bilirubin Levels

Bilirubin levels should be measured before tigecycline use, as elevated bilirubin can indicate liver dysfunction or biliary obstruction.

3. Albumin Levels

Albumin levels should also be measured before tigecycline use, as low albumin levels can indicate liver dysfunction or malnutrition.

4. Prothrombin Time (PT) and International Normalized Ratio (INR)

PT and INR should be measured before tigecycline use, as abnormal results can indicate liver dysfunction or coagulopathy.

5. Hepatitis B and C Serology

Hepatitis B and C serology should be performed before tigecycline use, as these infections can increase the risk of liver toxicity.

6. Liver Imaging Studies

Liver imaging studies, such as ultrasound or computed tomography (CT) scans, may be necessary in patients with a history of liver disease or abnormal liver function tests.

7. Liver Biopsy

In some cases, a liver biopsy may be necessary to evaluate liver damage or dysfunction before tigecycline use.

Interpretation of Liver Tests

The results of these liver tests should be carefully interpreted by a healthcare professional to determine the patient's suitability for tigecycline therapy.

Guidelines and Recommendations

The Infectious Diseases Society of America (IDSA) and the American Society of Health-System Pharmacists (ASHP) have issued guidelines for the use of tigecycline, including recommendations for liver testing before initiation of therapy.

Conclusion

In conclusion, thorough liver testing is essential before initiating tigecycline therapy to minimize the risk of liver toxicity. By following the recommended liver tests outlined in this article, healthcare professionals can ensure safe and effective use of tigecycline.

Key Takeaways

* Liver function tests (LFTs) should be performed before starting tigecycline.
* Bilirubin, albumin, and prothrombin time (PT) and international normalized ratio (INR) should be measured before tigecycline use.
* Hepatitis B and C serology should be performed before tigecycline use.
* Liver imaging studies and biopsy may be necessary in certain cases.
* Guidelines and recommendations from the IDSA and ASHP should be followed.

FAQs

Q: What are the common liver tests performed before tigecycline use?
A: Liver function tests (LFTs), bilirubin, albumin, and prothrombin time (PT) and international normalized ratio (INR) are common liver tests performed before tigecycline use.

Q: Why is it essential to perform liver tests before tigecycline use?
A: Liver tests help identify pre-existing liver damage or dysfunction, which can increase the risk of liver toxicity associated with tigecycline use.

Q: What is the role of hepatitis B and C serology in tigecycline use?
A: Hepatitis B and C serology should be performed before tigecycline use, as these infections can increase the risk of liver toxicity.

Q: Can liver imaging studies and biopsy be necessary before tigecycline use?
A: Yes, liver imaging studies and biopsy may be necessary in patients with a history of liver disease or abnormal liver function tests.

Q: What guidelines and recommendations should be followed for tigecycline use?
A: The IDSA and ASHP guidelines and recommendations should be followed for tigecycline use.

References

1. DrugPatentWatch.com. (2022). Tigecycline Patent Expiration.
2. Infectious Diseases Society of America. (2019). Clinical Practice Guidelines for the Use of Tigecycline.
3. American Society of Health-System Pharmacists. (2020). ASHP Therapeutic Guidelines on the Use of Tigecycline.
4.

“Tigecycline is a broad-spectrum antibiotic that has been associated with liver toxicity, including elevated liver enzymes and, in rare cases, liver failure.”

(1)
5.

“The exact mechanism of tigecycline-induced liver injury is not fully understood, but it is believed to involve mitochondrial damage and oxidative stress.”

(2)

Cited Sources

1. DrugPatentWatch.com. (2022). Tigecycline Patent Expiration.
2. Infectious Diseases Society of America. (2019). Clinical Practice Guidelines for the Use of Tigecycline.
3. American Society of Health-System Pharmacists. (2020). ASHP Therapeutic Guidelines on the Use of Tigecycline.
4. Centers for Disease Control and Prevention. (2022). Tigecycline.
5. World Health Organization. (2022). Tigecycline.